AnaptysBio, Inc. (ANAB)

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Biotechnology	-	-	-	-	10.29M
Royalty Management	106.09M	234.60M	91.28M	17.16M	-
Total	106.09M	234.60M	91.28M	17.16M	10.29M

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 1, 2026

Data Sources Report a data error